| Medical and Health Sciences | Lifetime | 588 | US 316 | 99.97 |
| Medical and Health Sciences | 2021-2025 | 561 | US 194 | 99.88 |
| Oncology | Lifetime | 29 | US 16 | 99.95 |
| Pulmonary and Respiratory Medicine | Lifetime | 32 | US 18 | 99.96 |
| Cancer Research | Lifetime | 241 | US 128 | 98.60 |
| Hepatology | Lifetime | 964 | US 356 | 72.78 |
| Oncology | 2021-2025 | 51 | US 20 | 99.73 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 74 | US 25 | 99.62 |
| Cancer Research | 2021-2025 | 208 | US 75 | 88.80 |
| Lung Cancer Treatments and Mutations | Lifetime | 4 | US 4 | 99.97 |
| Cancer Immunotherapy and Biomarkers | Lifetime | 19 | US 12 | 99.94 |
| Lung Cancer Diagnosis and Treatment | Lifetime | 14 | US 4 | 99.88 |
| Lung Cancer Research Studies | Lifetime | 14 | US 10 | 99.91 |
| Colorectal Cancer Treatments and Studies | Lifetime | 25 | US 14 | 99.83 |
| Cancer Genomics and Diagnostics | Lifetime | 75 | US 47 | 99.78 |
| Cancer, Hypoxia, and Metabolism | Lifetime | 77 | US 38 | 99.68 |
| HER2/EGFR in Cancer Research | Lifetime | 39 | US 21 | 99.75 |
| Angiogenesis and VEGF in Cancer | Lifetime | 62 | US 33 | 99.49 |
| Cancer Treatment and Pharmacology | Lifetime | 139 | US 77 | 99.55 |
| Peptidase Inhibition and Analysis | Lifetime | 261 | US 123 | 98.88 |
| Radiomics and Machine Learning in Medical Imaging | Lifetime | 407 | US 169 | 98.67 |
| PI3K/AKT/mTOR signaling in cancer | Lifetime | 150 | US 91 | 98.61 |
| Gastric Cancer Management and Outcomes | Lifetime | 768 | US 240 | 98.48 |
| Cancer Research and Treatments | Lifetime | 460 | US 272 | 97.56 |
| Cancer therapeutics and mechanisms | Lifetime | 381 | US 212 | 97.97 |
| CAR-T cell therapy research | Lifetime | 831 | US 481 | 97.82 |
| Hepatocellular Carcinoma Treatment and Prognosis | Lifetime | 911 | US 237 | 97.44 |
| Cell death mechanisms and regulation | Lifetime | 877 | US 353 | 94.56 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 51 | US 17 | 99.79 |
| Lung Cancer Diagnosis and Treatment | 2021-2025 | 25 | US 4 | 99.57 |
| Lung Cancer Treatments and Mutations | 2021-2025 | 36 | US 15 | 99.75 |
| Cancer Genomics and Diagnostics | 2021-2025 | 80 | US 46 | 99.31 |
| Lung Cancer Research Studies | 2021-2025 | 137 | US 56 | 98.18 |
| Colorectal Cancer Treatments and Studies | 2021-2025 | 472 | US 154 | 94.37 |
